Chinese researchers found Europeans genetically predisposed to getting up easily in the morning and having poor sleep duration had a higher risk of developing primary open-angle glaucoma (POAG).
More than a third of patients treated with steroid, carbonic anhydrase inhibitor and nonsteroidal anti-inflammatory (NSAID) drops achieved closure of full-thickness macular holes, said authors of a US
TheiaNova's novel, patented eye-drop for treatment of keratoconus won it a finalist place at the prestigious Eyecelerator Winning Pitch Challenge.
In a multinational survey of patients with inherited retinal diseases (IRDs), 90% indicated they were likely or very likely to take up gene therapy if it was available to them. Led by the University
Online hotlink: https://myopia.worldcouncilofoptometry.info/standard-of-care/
The Blink range of eye and contact lens drops is now available from Bausch + Lomb (B+L) after the global eye health company completed the product line’s acquisition from Johnson & Johnson Vision.
The annual Excellence in Ophthalmology and Vision Research awards celebrated emerging stars in ophthalmology and research.
LINK: https://nzoptics.co.nz/live-articles/atkinson-awarded/
LINK: https://nzoptics.co.nz/live-articles/patients-needed-for-castor-oil-study/
The highly anticipated launch of preservative-free eye drops marked a promising advance in treatment for Glaucoma patients
US researchers have discovered that some over-the-counter glucosamine supplementations are associated with increased intraocular pressure (IOP) and could contribute to the pathogenesis of glaucoma.
A new European research project will pioneer an artificial intelligence (AI) -based programme to identify and monitor age-related macular degeneration (AMD) at its earliest stages. Leveraging A